Alpha Tau Medical (DRTS) Other Accumulated Expenses (2020 - 2026)
Alpha Tau Medical (DRTS) posted Other Accumulated Expenses of $5.5 million for Q1 2026, little changed sequentially from $5.5 million in Q4 2025, and down 10.65% YoY from $6.2 million in Q1 2025.
Analysis
Alpha Tau Medical (DRTS) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Other Accumulated Expenses for 7 years, with the latest figure at $5.5 million in Q1 2026.
- Quarterly Other Accumulated Expenses fell 10.65% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (down 10.65% YoY) and the FY2025 annual result came in at $5.5 million, up 33.27% from the prior year.
- Other Accumulated Expenses steadied at $5.5 million in Q1 2026 per DRTS's latest filing, from $5.5 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $6.2 million in Q1 2025 and troughed at $1.6 million in Q2 2022.
- A 5-year average of $3.6 million and a median of $3.4 million in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses fell 29.86% in 2022, then soared 77.47% in 2023.
- Over 5 years, Other Accumulated Expenses stood at $2.2 million in 2022, then soared by 54.67% to $3.5 million in 2023, then gained by 18.97% to $4.1 million in 2024, then jumped by 33.27% to $5.5 million in 2025, then increased by 0.38% to $5.5 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $5.5 million, $5.5 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.21 Bn | 1.11 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 5.53 Mn |
| Dec 31, 2025 | 5.51 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Mar 31, 2025 | 6.19 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 3.12 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 2.47 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | 1.12 Mn |